Vakis Papanastassiou

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

R Rampling, G. Cruickshank, Vakis Papanastassiou et al. · Gene Therapy · 2000 · 594 citations

Neuro-oncology, Null Mutant 1716, Medicine +11

Prospective, Population-Based Detection of Intracranial Vascular Malformations in Adults

Rustam Al‐Shahi Salman, Jo J. Bhattacharya, David G Currie et al. · Stroke · 2003 · 436 citations

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

Stephen Harrow, Vakis Papanastassiou, J. Harland et al. · Gene Therapy · 2004 · 340 citations

Neuro-oncology, High-grade Glioma, Glioma +9

The potential for efficacy of the modified (ICP 34.5−) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

Vakis Papanastassiou, R Rampling, Matthew Fraser et al. · Gene Therapy · 2002 · 326 citations

Neuro-oncology, Cancer-associated Virus, Immunology +10

Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study

Rustam Al‐Shahi Salman, Julie Hall, Margaret Horne et al. · The Lancet Neurology · 2012 · 304 citations · Full text